Insider Holders & Insider Ownership - GT Biopharma Inc. (GTBP)

List of insiders holdings for GT Biopharma Inc.:
  1. Shares directly owned by the insider.
  2. Shares indirectly owned by the insider.
  3. Total shares owned by the insider (sum of shares directly and indirectly owned).
  4. Total market value if available.
  5. Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
# Insider Holder Name Report
Date Time
Shares Owned
Directly
Indirectly
Total
Shares Owned
Filing
1 Saloff David
CEO, Chairman of the Board
2012-05-30 16:58:12 27,650,684
0
27,650,684 Form 4
2 Clarence-Smith Kathleen
CEO
10% Owner
2017-12-01 17:25:39 8,505,633
0
8,505,633 Form 3
3 Silverman Mark J
10% Owner
2017-12-01 19:29:24 8,172,079
0
8,172,079 Form 13G
4 Cataldo Tony
CEO
10% Owner
2020-06-04 17:15:28 6,500,000
0
6,500,000 Form 4
5 Weldon Steven W
Former Officer and Director
Director
2020-12-23 16:24:42 3,720,000
0
3,720,000 Form 4
6 Theorem Group LLC
10% Owner
2017-11-14 10:15:23 3,540,130
0
3,540,130 Form 13G
7 HAUSMAN MARVIN S MD
President & CEO
2008-02-08 12:44:25 2,344,080
0
2,344,080 Form 5
8 Landes Bernard
President
2010-03-22 19:39:47 2,220,453
0
2,220,453 Form 3
9 ROGERS RAY R
CEO/Chairman of the Board
2003-12-11 15:10:19 1,827,988
0
1,827,988 Form 4/A
10 Urbanski Raymond W.
CEO
2019-03-19 14:38:04 1,351,918
0
1,351,918 Form 4
11 Guillen Steven T
President & CEO
2005-12-30 17:18:50 1,100,000
0
1,100,000 Form 4
12 Post Gary M
Former Director and Secretary
2010-09-02 18:05:28 900,000
0
900,000 Form 4
13 ELLIS SHARON
Chief Operational & Financial
2003-12-11 19:30:58 885,000
0
885,000 Form 4
14 Breen Michael Martin
Executive Chairman/Interim CEO
2023-08-15 19:29:58 856,218
0
856,218 Form 4
15 Ohri Manu
CFO & Secretary
2023-08-15 19:26:31 200,000
550,000
750,000 Form 4
16 Wendel Bruce
Director
2023-02-01 06:01:27 500,000
0
500,000 Form 4
17 SHROTRIYA RAJESH C MD
Director
2023-02-01 06:02:39 500,000
0
500,000 Form 4
18 CASAMENTO CHARLES J
Director
2023-06-21 19:58:43 500,000
0
500,000 Form 4
19 REPINE JOHN E
Director
2007-11-13 14:48:31 482,187
0
482,187 Form 4
20 RODELL TIMOTHY C JR
Director
2005-12-30 17:24:28 455,237
0
455,237 Form 4
21 WOLF THOMAS M
Director
2003-12-30 12:03:21 433,626
0
433,626 Form 4
22 NEILL SYDNEY COLIN
Director
2007-11-13 14:31:02 432,500
0
432,500 Form 4
23 Handelman Michael D
Chief Financial Officer
2010-03-22 19:52:13 250,000
0
250,000 Form 3
24 Eaton Kenneth Haynes
Director
2011-07-07 19:20:21 250,000
0
250,000 Form 3
25 DUBE ANSHUMAN
Director
2011-05-24 19:50:44 0
250,000
250,000 Form 4
26 HOOG THOMAS W
Director
2011-02-08 15:46:30 250,000
0
250,000 Form 3
27 CENTRON MICHAEL D
VP & CFO
2006-08-02 19:02:01 250,000
0
250,000 Form 4
28 Choy Gavin
Acting Chief Financial Officer
2022-02-14 16:09:22 227,500
0
227,500 Form 4
29 BRISTOL INVESTMENT FUND LTD
BRISTOL CAPITAL LLC
10% Owner
2024-05-23 20:31:08 190,000
0
190,000 Form 13G
30 BRISTOL INVESTMENT FUND LTD
10% Owner
2024-05-23 20:31:08 190,000
0
190,000 Form 13G
31 BRUINSMA GOSSE B
Chairman, Acting CEO
2004-10-13 17:46:27 135,000
0
135,000 Form 4
32 DAVIS RICHARD A
Director
2004-06-30 11:48:00 107,147
0
107,147 Form 4/A
33 ODonnell Manus H
Acting Chief Operating Officer
2004-12-27 16:37:45 100,000
0
100,000 Form 4
34 PRYOR WILLIAM G
Director
2003-12-08 21:30:58 87,602
0
87,602 Form 4
35 FERRIS STEVEN H
Director
2004-10-13 17:45:32 85,000
0
85,000 Form 4
36 VLAK GERARD J M
Director
2004-10-13 17:44:01 85,000
0
85,000 Form 4
37 Berk Gregory
Pres. of R&D, CMO
2022-07-19 21:44:55 50,000
0
50,000 Form 4
38 SPOLAR MATTHEW R
Director
2007-11-13 14:36:37 35,000
0
35,000 Form 4
39 WEBB TED FORD
Director
2003-12-09 15:07:03 31,754
0
31,754 Form 4/A
40 URBAN ALAN LOUIS
Chief Financial Officer
2024-10-21 21:13:40 23,335
0
23,335 Form 4
41 Cross Shawn
Chief Executive Officer
2018-03-16 17:14:20 0
0
0 Form 3
42 AXONYX INC
HAUSMAN MARVIN S MD
10% Owner
2008-10-03 20:29:42 0
0
0 Form 13D